Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

Author： Hayat Sawsan   Uppal Sukhbir   Narayanan Nampoory M.   Johny Kaivilayil   Gupta Ramkumar   Al-Oun Mohammed  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.26, Iss.6, 2007-06, pp. : 973-975

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis

By Takahashi Satoshi  

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 282-289

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus

By Hayat Sawsan Johar   Uppal Sukhbir Singh  

Modern Rheumatology, Vol. 17, Iss. 2, 2007-04 ,pp. : 174-177

Springer Publishing Company

Access to resources Recommend Favorite

A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept

By Akgül Özgür   Kılıç Gamze   Kılıç Erkan   Cüce İsa   Özgöçmen Salih  

Rheumatology International, Vol. 34, Iss. 3, 2014-03 ,pp. : 443-444

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of Lupus Enteritis in a Patient with Lupus Cystitis and Nephritis

By  

Digestion, Vol. 80, Iss. 3, 2009-09 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Study of the efficacy of mizoribine in lupus nephritis in Chinese patients

By Zhang Miao   Xing Chang   Liu Jia  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2737-2742

Springer Publishing Company

Access to resources Recommend Favorite